OUTCOMES OF NEOADJUVANT CHEMOTHERAPY FOR STAGE II–III TRIPLE-NEGATIVE BREAST CANCER AT NGHE AN ONCOLOGY HOSPITAL. YHCĐ 2026, 67 (Số CĐ12- Bệnh viện Ung bướu Nghệ An). https://doi.org/10.52163/yhc.v67iCD12.6147.